Quantcast

US IPO Weekly Recap: A quiet week ahead of 2018's final stretch


Shutterstock photo

No companies went public this past week, during the post-Thanksgiving lull.

Three healthcare deals joined the IPO calendar for next week. Messenger RNA developer  Moderna ( MRNA ) is the week's largest offering, aiming to raise $500 million in the biggest biotech IPO ever. 

There were no new IPO filings, aside from two SPACs. Blank check company  Andina Acquisition III ( ANDAU ) filed to raise $100 million to acquire a business in Latin America, while Chardan Healthcare Acquisition ( CHACU ) filed to raise $70 million as it explores a healthcare business to acquire. Therefore, what is currently in  the IPO pipeline  is what can go public in 2018; others will have to wait.

The IPO Index climbed 4.0% this past week, though it is still well below its level before the sell-off that began in October.

2 SPAC Filings During the Week of November 26th, 2018
Issuer
Business
Deal
Size
Sector Lead
Underwriter
Andina Acquisition III ( ANDAU ) $100M SPAC Cowen
Blank check company formed to acquire a business in Latin America.
Chardan Healthcare Acq. ( CHACU ) $70M SPAC Chardan
Blank check company formed by Chardan to acquire a healthcare business.

The article US IPO Weekly Recap: A quiet week ahead of 2018's final stretch originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.

Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital's Renaissance IPO ETF (symbol: IPO) , Renaissance International ETF (symbol: IPOS) , or separately managed institutional accounts may have investments in securities of companies mentioned.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



This article appears in: News Headlines , IPOs
Referenced Symbols: MRNA , ANDAU , CHACU



More from Renaissance Capital

Subscribe






Renaissance Capital
Contributor:

Renaissance Capital

IPOs










Research Brokers before you trade

Want to trade FX?